Kames Capital Management’s AbbVie ABBV Stock Holding History

Kames Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$130M	Buy	1,987,811 +77,975	+4%	+$4.92M	3.83%	3
2014 Q3	$110M	Sell	1,909,836 -2,374	-0.1%	-$132K	3.45%	3
2014 Q2	$108M	Sell	1,912,210 -6,122	-0.3%	-$321K	3.44%	3
2014 Q1	$98.6M	Buy	1,918,332 +1,333,854	+228%	+$67.4M	3.12%	4
2013 Q4	$30.9M	Sell	584,478 -69,383	-11%	-$3.41M	1.03%	35
2013 Q3	$29.3M	Sell	653,861 -9,332	-1%	-$414K	0.9%	35
2013 Q2	$27.4M	Buy	+663,193	New	+$29M	0.96%	33

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Kames Capital Management's ABBV Position: Q4 2014 in Review

Kames Capital Management increased its AbbVie (ABBV) stake by 4.1% in Q4 2014, buying an estimated $4.92M and bringing the position to 1,987,811 shares worth $130M. The position accounts for 3.83% of the portfolio, ranked #3.

Kames Capital Management first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

Kames Capital Management held 1,987,811 shares of AbbVie worth $130M as of Q4 2014.
Kames Capital Management bought 77,975 AbbVie shares in Q4 2014, an estimated $4.92M.
AbbVie made up 3.83% of Kames Capital Management's portfolio in Q4 2014, its #3 holding.
Kames Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
1,604 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Kames Capital Management's 13F filing for Q4 2014, filed 3 Feb 2015.